| GWAS |
- Brain morphology (min-P) ( 32665545
)
- Brain morphology (MOSTest) ( 32665545
)
- Cognitive function ( 25644384
)
- Cortical surface area (MOSTest) ( 32665545
)
- Cortical thickness (MOSTest) ( 32665545
)
- Educational attainment ( 25201988
)
- Metabolite levels ( 23823483
)
- Response to cognitive-behavioural therapy in anxiety disorder ( 26989097
)
- Subcortical volume (min-P) ( 32665545
)
- Subcortical volume (MOSTest) ( 32665545
)
- Tourette syndrome ( 30818990
)
|
- Breast cancer ( 23535729
29059683
)
- Cellular nuclear factor (erythroid-derived 2)-like 2 levels ( 30767168
)
- Cognitive decline rate in late mild cognitive impairment ( 26252872
)
- Estimated glomerular filtration rate ( 31152163
)
- Heel bone mineral density ( 30598549
)
- Metabolite levels ( 23823483
)
- Migraine ( 22683712
27322543
)
- Migraine - clinic-based ( 23793025
)
- Night sleep phenotypes ( 27126917
)
- Postprandial triglyceride response ( 32603185
)
- Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab) ( 25117820
)
- Systolic blood pressure ( 30224653
)
- Tonometry ( 17903302
)
|
